These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2140443)

  • 21. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats.
    Jacquemin E; de Kozak Y; Thillaye B; Courtois Y; Goureau O
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1187-96. PubMed ID: 8631633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycolysis and glycogen metabolism after inhibition of hexose monophosphate pathway in C6-GLIAL cells.
    Keller K; Kolbe H; Herken H; Lange K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):213-5. PubMed ID: 138094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of autoimmune uveitis by anti-CD4 antibody.
    Atalla L; Linker-Israeli M; Steinman L; Rao NA
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1264-70. PubMed ID: 1973156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.
    Jung W; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):424-32. PubMed ID: 2525671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulation of experimental autoimmune uveitis using a rat anti retinal S-antigen specific monoclonal antibody: evidence for a species difference.
    Dua HS; Liversidge J; Forrester JV
    Eye (Lond); 1989; 3 ( Pt 1)():69-78. PubMed ID: 2591601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of experimental autoimmune uveoretinitis by infusions of human therapeutic intravenous immunoglobulins in rats.
    Saoudi A; Hurez V; De Kozak Y; Kuhn J; Kaveri SV; Kazatchkine MD; Druet P; Bellon B
    Transplant Proc; 1993 Oct; 25(5):2838-9. PubMed ID: 8212254
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body.
    Bora NS; Kim MC; Kabeer NH; Simpson SC; Tandhasetti MT; Cirrito TP; Kaplan AD; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1056-66. PubMed ID: 7730015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of pentose cycle of A549 cells by 6-aminonicotinamide: consequences for aerobic and hypoxic radiation response and for radiosensitizer action.
    Varnes ME
    NCI Monogr; 1988; (6):199-203. PubMed ID: 2965307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gamma-aminobutyric acid transaminase with 6-aminonicotinamide in regions of the rat brain.
    Prakash MR; Baouer NZ
    Biochem Pharmacol; 1981 Mar; 30(6):663-4. PubMed ID: 6456007
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigen-specific suppressor cells in experimental autoimmune uveitis.
    Rao NA; Atalla L; Fong SL; Chen F; Linker-Israeli M; Steinman L
    Ophthalmic Res; 1992; 24(2):92-8. PubMed ID: 1535119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular lesions of 6-aminonicotinamide toxicosis in rabbits.
    Render JA; Carlton WW
    Vet Pathol; 1985 Jan; 22(1):72-7. PubMed ID: 3156443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Purification of retinal S-antigen and its uveiticogenic activity].
    Yang PZ
    Zhonghua Yan Ke Za Zhi; 1990 Sep; 26(5):293-7. PubMed ID: 2086142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of inhibition of hexosemonophosphate shunt on the metabolism of glucose and function in rat brain in vivo.
    Gaitonde MK; Evans GM
    Neurochem Res; 1982 Sep; 7(9):1163-79. PubMed ID: 6217428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative pathways of glucose utilization in brain; changes in the pattern of glucose utilization in brain resulting from treatment of rats with 6-aminonicotinamide.
    Hothersall JS; Zubairu S; McLean P; Greenbaum AL
    J Neurochem; 1981 Dec; 37(6):1484-96. PubMed ID: 6460850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats.
    Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of experimental uveitis in rats by anti-I-A antibodies.
    Rao NA; Atalla L; Linker-Israeli M; Chen FY; George FW; Martin WJ; Steinman L
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2348-55. PubMed ID: 2681045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the pentose phosphate shunt in thyrotropin-induced thyroid hormone secretion: in vivo and vitro studies with 6-aminonicotinamide in mouse thyroids.
    Hashizume K; Onaya T; Sato A
    Endocrinology; 1975 Oct; 97(4):962-8. PubMed ID: 172320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of anti-inflammatory drugs on experimental uveitis.
    Anand SI; Waterbury LD; Pagliaro L; Zamir E; Rao NA
    Proc West Pharmacol Soc; 2001; 44():147-9. PubMed ID: 11793964
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental melanin-protein induced uveitis (EMIU) is the sole type of uveitis evoked by a diversity of ocular melanin preparations and melanin-derived soluble polypeptides.
    Broekhuyse RM; Kuhlmann ED; Winkens HJ
    Jpn J Ophthalmol; 1996; 40(4):459-68. PubMed ID: 9130050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free radical tissue damages in the anterior segment of the eye in experimental autoimmune uveitis.
    Ishimoto S; Wu GS; Hayashi S; Zhang J; Rao NA
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):630-6. PubMed ID: 8595963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.